Financials data is unavailable for this security.
View more
Year on year Healthlead PCL had net income fall -36.84% from 118.23m to 74.68m despite a 7.64% increase in revenues from 1.52bn to 1.64bn. An increase in the selling, general and administrative costs as a percentage of sales from 16.42% to 18.77% was a component in the falling net income despite rising revenues.
| Gross margin | 23.13% |
|---|---|
| Net profit margin | 4.23% |
| Operating margin | 5.57% |
| Return on assets | 5.64% |
|---|---|
| Return on equity | 8.11% |
| Return on investment | 6.60% |
More ▼
Cash flow in THBView more
In 2023, Healthlead PCL increased its cash reserves by 128.77%, or 188.46m. Cash Flow from Investing totalled 177.28m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company generated 91.26m in cash from operations while cash used for financing totalled 80.08m.
| Cash flow per share | 0.5211 |
|---|---|
| Price/Cash flow per share | 15.35 |
| Book value per share | 3.52 |
|---|---|
| Tangible book value per share | 3.43 |
More ▼
Balance sheet in THBView more
| Current ratio | 3.74 |
|---|---|
| Quick ratio | 2.45 |
| Total debt/total equity | 0.2731 |
|---|---|
| Total debt/total capital | 0.2145 |
More ▼
Growth rates in THB
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -16.67% and -36.84%, respectively.
| Div yield(5 year avg) | -- |
|---|---|
| Div growth rate (5 year) | -- |
| Payout ratio (TTM) | 53.54% |
| EPS growth(5 years) | -- |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -18.91 |
More ▼
